Non-ambulatory Duchenne muscular dystrophy: observations, interventions, and outcomes on a single case
Keywords:
Duchenne Muscular Dystrophy; non-ambulatory; gene deletion; outcome
Abstract
Duchenne muscular dystrophy (DMD) is a X-linked recessive gene defect manifesting as a fatal, progressive neuromuscular disease. Treatment goals aim to inhibit disease progression, increase patients’ quality of life, and lengthen life expectancy. We report here a single case of non-ambulatory DMD.
References
1. Emery AE. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord. 1991;1:19–29. DOI: https://doi.org/10.1016/0960-8966(91)90039-u.
2. Romitti PA, Zhu Y, Puzhankara S, James KA, Nabukera SK, Zamba GK, et al. Prevalence of Duschenne and Becker Muscular Dystrophies in the United States. Pediatrics. 2015;135:513–21. DOI: https://doi.org/10.1542/peds.2014-2044.
3. Passamano L, Taglia A, Palladino A, Viggiano E, D'Ambrosio, Scutifero M, et al. Improvement of survival in Duchenne Muscular Dystrophy?: retrospective analysis of 835 patients. Acta Myol. 2012;121–5. PMID : 23097603.
4. Van Ruiten HJA, Bettolo MC, Cheetham T, Eagle M, Lochmuller H, Straub V, et al. Why are some patients with Duchenne muscular dystrophy dying young?: An analysis of causes of death in North East England. Eur J Paediatr Neurol. 2016;20:904–9. DOI : https://doi.org/10.1016/j.ejpn.2016.07.0201.
5. Suthar R, Sankhyan N. Duchenne Muscular Dystrophy?: a practice update. Indian J Pediatr. 2018;85:276-81. DOI: https://doi.org/10.1007/s12098-017-2397-y.
6. Iskandar K, Sunartini, Nugrahanto AP, Ilma N, Kalim AS, Adistyawan G, et al. Use of air stacking to improve pulmonary function in Indonesian Duchenne muscular dystrophy patients: Bridging the standard of care gap in low middle income country setting. BMC Proc. 2019;13-21. PMID : 31890014.
7. Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, et al. The burden of Duchenne muscular dystrophy. Neurology. 2014;83:529–36. DOI: https://doi.org/10.1212/WNL.0000000000000669.
8. Griffith R, Edwars R. A new chart for weight control in Duschenne muscular dystrophy. Arch Dis Child. 1988;1256–8.
9. Davidson ZE, Truby H. A review of nutrition in Duchenne muscular dystrophy. J Hum Nutr Diet. 2009;22:383–93. DOI: https://doi.org/10.1111/j.1365-277X.2009.00979.x.
10. Baiardini I, Balestracci S, Walter C, Braido F, Rhinitis A. Quality of life in Duchenne muscular dystrophy?: the subjective impact on children and parents. J Child Neurol. 2011;26: 707-13. DOI: https://doi.org/10.1177/0883073810389043.
11. Deighton A, Szabo S, Salhany R, Harwood M, Mah J, Gooch K. Pro63 the natural history of Duchenne muscular dystrophy in the corticosteroid era: a systematic review of studies from Canada and the US. Value Heal. 2019;22:S852. DOI: https://doi.org/10.1016/j.jval.2019.09.2393.
12. Wein N, Alfano L, Flanigan KM. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy. Pediatr Clin North Am. 2015;62:723–42. DOI: https://doi.org/10.1016/j.pcl.2015.03.008.
13. Lee T, Takeshima Y, Kusunoki N, Awano H, Yagi M, Matsuo M, et al. Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients. J Hum Genet. 2014;59:46–50. DOI: https://doi.org/10.1038/jhg.2013.119.
14. Toussaint M, Pernet K, Steens M, Haan J, Sheers N. Cough augmentation in subjects with duchenne muscular dystrophy: Comparison of air stacking via a resuscitator bag versus mechanical ventilation. Respir Care. 2016;61:61–7. DOI: https://doi.org/10.4187/respcare.04033
15. Liang W, Wang C, Chou P. The natural history of the patients with Duchenne muscular dystrophy in Taiwan?: a medical center experience. Pediatr Neonatol. 2017;1–8. DOI: https://doi.org/10.1016/j.pedneo.2017.02.004
16 Emery A. Duschenne Muscular Dystrophy. Motulsky AG, Harper PS, Borrow M, Scriver C, editors. 2nd ed. New York: Oxford University Express; 1993. p. 38.
17. Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, et al. Cardiac management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142:S72-81. DOI: https://doi.org/10.1542/peds.2018-0333I
18. Mavrogeni SI, Markousis-Mavrogenis G, Papavasiliou A, Papadopoulos G, Kolovou G. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies. Methods Mol Biol. 2018;1687:31-42. DOI: https://doi.org/10.1007/978-1-4939-7374-3_3.
19. Nascimento Osorio A, Medina Cantillo J, Camacho Salas A, Madruga Garrido M, Vilchez Padilla JJ. Consensus on the diagnosis, treatment and follow-up of patients with Duchenne muscular dystrophy. Neurología. 2019; 34(7):469-481. DOI: https://doi.org/10.1016/j.nrl.2018.01.001
20. Takeuchi F, Komaki H, Nakamura H, Yonemoto N, Kashiwabara K, Kimura E, et al. Trends in steroid therapy for Duchenne muscular dystrophy in Japan. Muscle and Nerve. 2016;54:673–80. DOI: https://doi.org/10.1002/mus.25083
21. Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy (Review). Cochrane Database Syst Rev. 2016;2016:CD003725. DOI : https://doi.org/10.1002/14651858.CD003725.pub4.
22. Sussman MM. Duchenne muscular dystrophy. J Am Acad Orthop Surg. 2002;10:138–51. DOI: https://doi.org/10.5435/00124635-200203000-00009.
23. Al-Dahhak R, Kissel JT. Medical management of Duchenne muscular dystrophy: In: Chamberlain JS, Rando TA, editors. Duchenne muscular dystrophy: advances in therapeutics. New York and London: Taylor and Francis, Inc.; 2006. p. 123–35.
24. Darras BT, Urion DK, Ghosh PS. Corticosteroid Therapy in DMD. Dystrophinopathies Gene Rev. 2018;1–3.
25. McDonald CM, Henricson EK, Abresch RT, Duong T, Joyce NC, Hu F, et al. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet. 2018;391:451–61. DOI: https://doi.org/10.1016/S0140-6736(17)32160-8
26. Archer JE, Gardner AC, Roper HP, Chikermane AA, Tatman AJ. Duchenne muscular dystrophy: the management of scoliosis. J Spine Surg. 2016;2:185–94. DOI: https://doi.org/10.21037/jss.2016.08.05
27. Apkon SD, Alman B, Birnkrant DJ, Fitch R, Lark R, MacKenzie W, et al. Orthopedic and surgical management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142:S82–9. DOI: https://doi.org/10.1542/peds.2018-0333J.
28. Bachrach LK. Taking steps towards reducing osteoporosis in Duchenne muscular dystrophy. Neuromuscul Disord. 2005;15:86–7. DOI: https://doi.org/10.1016/j.nmd.2004.10.011.
29. Farrar M, Perera N. Bone Health in Children with Duchenne Muscular Dystrophy: A Review. Pediatr Ther. 2015;05:252. DOI: https://doi.org/10.4172/2161-0665.1000252
30. Salera S, Menni F, Moggio M, Guez S, Sciacco M, Esposito S. Nutritional challenges in duchenne muscular dystrophy. Nutrients. 2017;9:594. DOI: https://doi.org/10.3390/nu9060594
31. Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. 2018;17:347–61. DOI: https://doi.org/10.1016/S1474-4422(18)30025-5.
32. I Iskandar K, Dwianingsih EK, Pratiwi L, Kalim AS, Mardhiah H, Putranti AH, et al. The analysis of DMD gene deletions by multiplex PCR in Indonesian DMD/BMD patients: the era of personalized medicine. BMC Res Notes. 2019;12:704. DOI: https://doi.org/10.1186/s13104-019-4730-1.
33. Finder JD, Birnkrant D, Carl J, Farber HJ, Gozal D, Iannaccone ST, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med. 2004;170:456–65. DOI: https://doi.org/10.1164/rccm.200307-885ST.
2. Romitti PA, Zhu Y, Puzhankara S, James KA, Nabukera SK, Zamba GK, et al. Prevalence of Duschenne and Becker Muscular Dystrophies in the United States. Pediatrics. 2015;135:513–21. DOI: https://doi.org/10.1542/peds.2014-2044.
3. Passamano L, Taglia A, Palladino A, Viggiano E, D'Ambrosio, Scutifero M, et al. Improvement of survival in Duchenne Muscular Dystrophy?: retrospective analysis of 835 patients. Acta Myol. 2012;121–5. PMID : 23097603.
4. Van Ruiten HJA, Bettolo MC, Cheetham T, Eagle M, Lochmuller H, Straub V, et al. Why are some patients with Duchenne muscular dystrophy dying young?: An analysis of causes of death in North East England. Eur J Paediatr Neurol. 2016;20:904–9. DOI : https://doi.org/10.1016/j.ejpn.2016.07.0201.
5. Suthar R, Sankhyan N. Duchenne Muscular Dystrophy?: a practice update. Indian J Pediatr. 2018;85:276-81. DOI: https://doi.org/10.1007/s12098-017-2397-y.
6. Iskandar K, Sunartini, Nugrahanto AP, Ilma N, Kalim AS, Adistyawan G, et al. Use of air stacking to improve pulmonary function in Indonesian Duchenne muscular dystrophy patients: Bridging the standard of care gap in low middle income country setting. BMC Proc. 2019;13-21. PMID : 31890014.
7. Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, et al. The burden of Duchenne muscular dystrophy. Neurology. 2014;83:529–36. DOI: https://doi.org/10.1212/WNL.0000000000000669.
8. Griffith R, Edwars R. A new chart for weight control in Duschenne muscular dystrophy. Arch Dis Child. 1988;1256–8.
9. Davidson ZE, Truby H. A review of nutrition in Duchenne muscular dystrophy. J Hum Nutr Diet. 2009;22:383–93. DOI: https://doi.org/10.1111/j.1365-277X.2009.00979.x.
10. Baiardini I, Balestracci S, Walter C, Braido F, Rhinitis A. Quality of life in Duchenne muscular dystrophy?: the subjective impact on children and parents. J Child Neurol. 2011;26: 707-13. DOI: https://doi.org/10.1177/0883073810389043.
11. Deighton A, Szabo S, Salhany R, Harwood M, Mah J, Gooch K. Pro63 the natural history of Duchenne muscular dystrophy in the corticosteroid era: a systematic review of studies from Canada and the US. Value Heal. 2019;22:S852. DOI: https://doi.org/10.1016/j.jval.2019.09.2393.
12. Wein N, Alfano L, Flanigan KM. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy. Pediatr Clin North Am. 2015;62:723–42. DOI: https://doi.org/10.1016/j.pcl.2015.03.008.
13. Lee T, Takeshima Y, Kusunoki N, Awano H, Yagi M, Matsuo M, et al. Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients. J Hum Genet. 2014;59:46–50. DOI: https://doi.org/10.1038/jhg.2013.119.
14. Toussaint M, Pernet K, Steens M, Haan J, Sheers N. Cough augmentation in subjects with duchenne muscular dystrophy: Comparison of air stacking via a resuscitator bag versus mechanical ventilation. Respir Care. 2016;61:61–7. DOI: https://doi.org/10.4187/respcare.04033
15. Liang W, Wang C, Chou P. The natural history of the patients with Duchenne muscular dystrophy in Taiwan?: a medical center experience. Pediatr Neonatol. 2017;1–8. DOI: https://doi.org/10.1016/j.pedneo.2017.02.004
16 Emery A. Duschenne Muscular Dystrophy. Motulsky AG, Harper PS, Borrow M, Scriver C, editors. 2nd ed. New York: Oxford University Express; 1993. p. 38.
17. Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, et al. Cardiac management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142:S72-81. DOI: https://doi.org/10.1542/peds.2018-0333I
18. Mavrogeni SI, Markousis-Mavrogenis G, Papavasiliou A, Papadopoulos G, Kolovou G. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies. Methods Mol Biol. 2018;1687:31-42. DOI: https://doi.org/10.1007/978-1-4939-7374-3_3.
19. Nascimento Osorio A, Medina Cantillo J, Camacho Salas A, Madruga Garrido M, Vilchez Padilla JJ. Consensus on the diagnosis, treatment and follow-up of patients with Duchenne muscular dystrophy. Neurología. 2019; 34(7):469-481. DOI: https://doi.org/10.1016/j.nrl.2018.01.001
20. Takeuchi F, Komaki H, Nakamura H, Yonemoto N, Kashiwabara K, Kimura E, et al. Trends in steroid therapy for Duchenne muscular dystrophy in Japan. Muscle and Nerve. 2016;54:673–80. DOI: https://doi.org/10.1002/mus.25083
21. Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy (Review). Cochrane Database Syst Rev. 2016;2016:CD003725. DOI : https://doi.org/10.1002/14651858.CD003725.pub4.
22. Sussman MM. Duchenne muscular dystrophy. J Am Acad Orthop Surg. 2002;10:138–51. DOI: https://doi.org/10.5435/00124635-200203000-00009.
23. Al-Dahhak R, Kissel JT. Medical management of Duchenne muscular dystrophy: In: Chamberlain JS, Rando TA, editors. Duchenne muscular dystrophy: advances in therapeutics. New York and London: Taylor and Francis, Inc.; 2006. p. 123–35.
24. Darras BT, Urion DK, Ghosh PS. Corticosteroid Therapy in DMD. Dystrophinopathies Gene Rev. 2018;1–3.
25. McDonald CM, Henricson EK, Abresch RT, Duong T, Joyce NC, Hu F, et al. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet. 2018;391:451–61. DOI: https://doi.org/10.1016/S0140-6736(17)32160-8
26. Archer JE, Gardner AC, Roper HP, Chikermane AA, Tatman AJ. Duchenne muscular dystrophy: the management of scoliosis. J Spine Surg. 2016;2:185–94. DOI: https://doi.org/10.21037/jss.2016.08.05
27. Apkon SD, Alman B, Birnkrant DJ, Fitch R, Lark R, MacKenzie W, et al. Orthopedic and surgical management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142:S82–9. DOI: https://doi.org/10.1542/peds.2018-0333J.
28. Bachrach LK. Taking steps towards reducing osteoporosis in Duchenne muscular dystrophy. Neuromuscul Disord. 2005;15:86–7. DOI: https://doi.org/10.1016/j.nmd.2004.10.011.
29. Farrar M, Perera N. Bone Health in Children with Duchenne Muscular Dystrophy: A Review. Pediatr Ther. 2015;05:252. DOI: https://doi.org/10.4172/2161-0665.1000252
30. Salera S, Menni F, Moggio M, Guez S, Sciacco M, Esposito S. Nutritional challenges in duchenne muscular dystrophy. Nutrients. 2017;9:594. DOI: https://doi.org/10.3390/nu9060594
31. Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. 2018;17:347–61. DOI: https://doi.org/10.1016/S1474-4422(18)30025-5.
32. I Iskandar K, Dwianingsih EK, Pratiwi L, Kalim AS, Mardhiah H, Putranti AH, et al. The analysis of DMD gene deletions by multiplex PCR in Indonesian DMD/BMD patients: the era of personalized medicine. BMC Res Notes. 2019;12:704. DOI: https://doi.org/10.1186/s13104-019-4730-1.
33. Finder JD, Birnkrant D, Carl J, Farber HJ, Gozal D, Iannaccone ST, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med. 2004;170:456–65. DOI: https://doi.org/10.1164/rccm.200307-885ST.
Published
2022-07-06
How to Cite
1.
Noer S, Sunartini S, Suryantoro P. Non-ambulatory Duchenne muscular dystrophy: observations, interventions, and outcomes on a single case. PI [Internet]. 6Jul.2022 [cited 19Apr.2024];62(3):208-6. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2447
Section
Case Report
Copyright (c) 2022 Sevria Yetty Anggraina Noer, Sunartini -, Purnomo Suryantoro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Received 2020-07-13
Accepted 2022-07-06
Published 2022-07-06
Accepted 2022-07-06
Published 2022-07-06
